NR1H4 and carcinoma: NR1H4, also known as Farnesoid X Receptor (FXR), acts as a nuclear receptor that is predominantly expressed in the liver and intestines and can be activated by binding to bile acids (BAs), and altering its expression can influence bladder carcinogenesis (50, 51).